Twist Bioscience Corporation (BIT:1TWST)
Italy flag Italy · Delayed Price · Currency is EUR
29.09
+1.43 (5.17%)
At close: May 12, 2025

Twist Bioscience Company Description

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.

The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development.

It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution.

In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses.

Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody.

The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Twist Bioscience Corporation
Country United States
Founded 2013
Industry Biological Products, Except Diagnostic Substances
Employees 923
CEO Emily Leproust

Contact Details

Address:
681 Gateway Boulevard
South San Francisco, Delaware 94080
United States
Phone 800 719 0671
Website twistbioscience.com

Stock Details

Ticker Symbol 1TWST
Exchange Borsa Italiana
Stock Type Common Stock
Fiscal Year October - September
Reporting Currency USD
SIC Code 2836

Key Executives

Name Position
Emily Leproust Chief Executive Officer
Adam Laponis Chief Financial Officer
Patrick Finn Chief Operating Officer